Purchase Order W913E524P0025
Award Date
4/5/24
Potential Completion Date
4/7/27
Potential Value
$17K
Federal Agency
Engineer Research and Development Center
Awardee
Molecular Devices LLC
Ultimate Awardee
Not listed
NAICS Category
334516 - Analytical Laboratory Instrument Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Jose, CA 95134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price purchase order awarded by the Office of Logistics and Acquisition Operations, a civilian agency, to Molecular Devices LLC, a division of Danaher Corporation, for a service maintenance plan for a SpectraMax M3 Multimode Reader. The contract has a ceiling value of $54,173.00 and a completion date of August 7, 2025. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contract awards from agencies...
This is a firm-fixed-price purchase order awarded by the Smithsonian Institution, a civilian federal agency, to Molecular Devices LLC, a division of Danaher Corporation, for the purchase of a SpectraMax iD3 microplate reader. The total ceiling value of the contract is $36,746.26 and the ultimate completion date is February 29, 2024. No set-aside was used for this award. Molecular Devices LLC is a leading provider of high-performance bioanalytical measurement solutions for life science...
This firm-fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a division of Danaher Corporation, to procure a SpectraMax iD3 multi-mode microplate reader. The $24,994.92 contract will replace an existing, non-functioning instrument due to software/operating system incompatibilities. Molecular Devices is a leading provider of bioanalytical measurement solutions and has received numerous prime federal contracts from agencies like the NIH,...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a civilian agency within the National Institutes of Health, to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The contract is for a SERVICE AGREEMENT FOR SPECTRAMAX ID3 PLATE READER, with a ceiling value of $10,932.00 and a period of performance ending on July 14, 2026. The contract has no set-aside designation. Molecular Devices LLC is a manufacturer...
This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Molecular Devices LLC, a subsidiary of Danaher Corporation. The contract is for the provision of a microplate reader and accessories with a ceiling value of $23,350.77. The contract has an ultimate completion date of November 14, 2014. Molecular Devices LLC is a for-profit limited liability company that specializes in advanced bioanalytical measurement solutions and has a strong presence in...
This is a firm-fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health's National Cancer Institute to Molecular Devices LLC, a division of Danaher Corporation, for a SERVICE AGREEMENT FOR SPECTRAMAX M3 MULTI-MODE MICROPLATE READER. The potential value of the contract is $14,122.00 and the completion date is June 24, 2025. Molecular Devices LLC is a major provider of high-performance bioanalytical measurement solutions for life sciences...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute, a component of the National Institutes of Health, to Molecular Devices LLC, a for-profit limited liability company and subsidiary of Danaher Corporation. The contract is for the procurement of a SpectraMax L luminescence microplate reader with the current version of SoftMax Pro software. The total ceiling value of the contract is $16,710.65 and the ultimate completion date is August 31, 2025. The...
This is a federal purchase order awarded by the National Institutes of Health (NIAID DEA OA Acquisitions) to Molecular Devices LLC, a subsidiary of Danaher Corporation, for the provision of a SPECTRAMAX I3 MULTI-MODE MICROPLATE DETECTION PLATFORM and an annual maintenance agreement. The contract has a firm-fixed price of $62,197.00 and a completion date of May 6, 2015. There was no set-aside used for this award. Molecular Devices LLC is a leading provider of bioanalytical measurement solutions...
This is a federal contract award to Molecular Devices LLC, a subsidiary of Danaher Corporation, to provide a SpectraMax I3X multi-mode detection platform to the U.S. Environmental Protection Agency's (EPA) Office of Research and Development. The firm-fixed-price purchase order, worth $13,099.50, was awarded on May 23, 2024 and has an ultimate completion date of August 7, 2025. The contract does not have a set-aside designation. Molecular Devices LLC is a for-profit limited liability company that...
This is a firm-fixed-price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Molecular Devices LLC, a division of Danaher Corporation. The contract is for a SPECTRAMAX ID3 SERVICE PLAN 1PM, ONSITE PERFORMANCE ASSURANCE with a ceiling value of $10,217.00 and a period of performance ending on October 31, 2025. The contract does not have a set-aside designation. Molecular Devices LLC is a leading provider of...